ASCI upholds complaints against 125 misleading ads

Image
Press Trust of India New Delhi
Last Updated : Apr 23 2015 | 7:48 PM IST
Advertising industry watchdog ASCI has upheld complaints against 125 misleading campaigns by companies such as Idea Cellular, Dabur, GlaxoSmithKline (GSK) Consumer and Heinz during February this year.
According to the Customer Complaints Council (CCC) of ASCI (Advertising Standard Council of India), it received 167 complaints during February and a maximum of 73 complaints of misleading ads were upheld from the personal and healthcare category.
The council upheld complaint against advertisement of Idea Cellular which showed "the practise in Haryana of girls not being allowed to step out of homes to study, is defaming Haryana and tends to bring this state into disrepute."
"Also, the TVC is misleading by implication as the product/service promoted (Idea Internet Network) is shown as a substitute to and equating to college education," it added.
It also upheld a case against Heinz India's advertisement of its product 'Glucon D - Volt'.
"The visual of the advertisement shows kids flipping the Glucon-D Volt tablet into the air and catching in the mouth directly, which is seen as a dangerous act and is likely to encourage minors to emulate such act in a manner which could cause harm or injury," it said.
GlaxoSmithKline Consumer Healthcare Ltd was pulled up for its product Horlicks' advertisement.
"It suggests that consumption of Horlicks can be initiated at the time of exams for better concentration. It is misleading by ambiguity as the product has to be consumed for a considerable period of time to be effective," ASCI said.
Complaint against another FMCG firm Dabur's was upheld for making unsubstantiated claims.
"Dabur advertisement claims that Dabur Chyawanprash gives three times more immunity which makes kids strong from within and increases immunity that is the ability to fight illness by three times, were unsubstantiated," ASCI added.
ASCI also upheld complaints against advertisements of several educational institutes, including Institute of management studies (IMS), Ghaziabad, IMS learning resources, Triumphant Institute of Management Education P Ltd (TIME) and Institute of Finance Banking & Insurance (IFBI).
"Complaints against 29 advertisements of educational institutes were upheld for making unsubstantiated claims that they provide 100 per cent placement and/or they claim to be the No.1 in their respective fields," it said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 23 2015 | 7:48 PM IST

Next Story